Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2000
12/14/2000WO2000075306A2 Method for producing double stranded polynucleotides
12/14/2000WO2000075303A1 Primers for polymerase reactions
12/14/2000WO2000075302A2 Isolation of nucleic acid
12/14/2000WO2000075278A2 Gene encoding nade, p75ntr-associated cell death executor and uses thereof
12/14/2000WO2000075277A2 A MOLECULAR MARKER BASED ON THE Frk2 (FRUCTOKINASE 2) GENE
12/14/2000WO2000075276A2 Dna detector based on molecular controlled semiconductor resistor
12/14/2000WO2000075190A2 Hybridomas for lung cancer marker and monoclonal antibodies thereof
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075179A1 Chromatographic determination of p-glycoprotein reactive ligands
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075169A1 Novel fabh enzyme, compositions capable of binding to said enzyme and methods of use thereof
12/14/2000WO2000075167A2 Phosphorylation assays
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000074725A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000WO2000074717A1 NOVEL Ig FRACTIONS HAVING AN IMMUNOMODULATORY ACTIVITY
12/14/2000WO2000074687A1 Antisense modulation of b7 protein expression
12/14/2000WO2000074686A1 Modulators of methylation for control of bacterial virulence
12/14/2000WO2000074671A1 Method and markers for prognosticating efficacy of anticancer agents
12/14/2000WO2000074667A2 Compositions active in telomere damage comprising a taxane and telomerase inhibitor
12/14/2000WO2000063419B1 Combinatorial chemical library supports having indicia at coding positions and methods of use
12/14/2000WO2000055355A3 Method of screening candidate compounds for susceptibility to biliary excretion
12/14/2000WO2000054049A3 Determination of the chemosensitivity via the caspase activity
12/14/2000WO2000053776A3 Human kallikrein-like genes
12/14/2000WO2000053749A3 Vascular adhesion molecules and modulation of their function
12/14/2000WO2000050902A3 High throughput assay based on the use of a polypeptide binding pair
12/14/2000WO2000050564A3 Method for extracting dna from dried specimens
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000049178A3 Polynucleotide sequencing method
12/14/2000WO2000049141A3 A method for production and delivery of a protein in vivo
12/14/2000WO2000049039A3 Glucose dehydrogenase fusion proteins and their utilization in expression systems
12/14/2000WO2000047612A3 Structure-based screening techniques for drug discovery
12/14/2000WO2000046392A3 Method for determining microbial contamination
12/14/2000WO2000046236A3 Novel rgs-containing molecules and uses thereof
12/14/2000WO2000043546A9 Detection of drug resistant organisms
12/14/2000WO2000043498A3 Human liver progenitors
12/14/2000WO2000033872A9 Method of and compositions for immunization with the pseudomonas v antigen
12/14/2000DE19926771A1 Nukleinsäuremoleküle aus Weizen, transgene Pflanzenzellen und Pflanzen und deren Verwendung für die Herstellung modifizierter Stärke Nucleic acid molecules from wheat, transgenic plant cells and plants and their use for the production of modified starch
12/14/2000DE19926728A1 Deformable, hardenable or film-forming carrier containing intraoral diagnostic additives, useful for the simultaneous detection of multiple oral conditions
12/14/2000DE19925862A1 Verfahren zur Synthese von DNA-Fragmenten Process for the synthesis of DNA fragments
12/14/2000DE10023923A1 Verfahren zur Bestimmung der Aktivität der Faktor VII-aktivierenden Protease aus Proteinlösungen A method for determining the activity of the factor VII-activating protease from protein solutions
12/14/2000CA2504679A1 Compositions and methods for the treatment of tumor
12/14/2000CA2501815A1 Compositions and methods for the treatment of tumor
12/14/2000CA2378822A1 Solid phase methods for amplifying multiple nucleic acids
12/14/2000CA2376825A1 Chromatographic determination of p-glycoprotein reactive ligands
12/14/2000CA2376642A1 Recombinant nematode nicotinic receptor and uses
12/14/2000CA2376438A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000CA2376400A1 Compounds and methods to enhance raav transduction
12/14/2000CA2376335A1 Novel ig fractions having an immunomodulatory activity
12/14/2000CA2376314A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000CA2376192A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376058A1 Use of the regulatory subunit of the camp dependent protein kinase (pka) from dictyostelium for camp measurements
12/14/2000CA2376055A1 Spliceosomal protein and its use
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2375876A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000CA2375861A1 Method and markers for prognosticating efficacy of anticancer agents
12/14/2000CA2375433A1 Transcription-based gene mapping
12/14/2000CA2375145A1 Substrate trapping protein tyrosine phosphatases
12/14/2000CA2374664A1 In vivo selection method for determining inhibitory rna molecules
12/14/2000CA2374587A1 Hybridomas for lung cancer marker and monoclonal antibodies thereof
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2374390A1 Combinatorial decoding of random nucleic acid arrays
12/14/2000CA2373340A1 Nmr-solve method for rapid identification of bi-ligand drug candidates
12/14/2000CA2373069A1 Assay for detecting the enzymatic activity of a phosphorylation enzyme using enhanced signal generation
12/14/2000CA2371434A1 Compositions and methods for the treatment of tumor
12/14/2000CA2339255A1 Hepg2 cells stably transfected with hcv
12/13/2000EP1059523A2 Automated real-time analysis of nucleic acid amplification
12/13/2000EP1059359A2 Method for the determination of the activity of the Factor VII-activating protease in protein solutions
12/13/2000EP1059088A1 New Ig-fractions with immunomodulation activity
12/13/2000EP1058742A1 Screening for functional antisense agents
12/13/2000EP1058741A1 Screening for functional antisense agents
12/13/2000EP1058740A1 Multi-zone polymerase/ligase chain reaction
12/13/2000EP1058739A1 Method for generating gene expression profiles
12/13/2000EP1058738A2 A fluorescence polarization screening method
12/13/2000EP1058737A1 Novel fdrg protein and nucleic acid molecules and uses therefor
12/13/2000EP1058730A1 Human synapse related glycoproteins (hsrp)
12/13/2000EP1058728A1 V-like domain binding molecules
12/13/2000EP1058727A1 Materials and methods for identifying and analyzing intermediate tandem repeat dna markers
12/13/2000EP1058726A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058688A1 Specific oligonucleotide primers for detection of bovine male chromosome presence by polymerase chain reaction and method
12/13/2000EP1058500A1 The helios gene
12/13/2000EP0444115B2 In situ suppression hybridization and uses therefor
12/13/2000EP0230472B2 Biosensor and method of manufacturing same
12/13/2000CN1276832A Composition and method for identifying PKB kinase inhibitors
12/13/2000CN1276725A Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma
12/13/2000CN1276427A Process for preparing allelic gene step of shortly serial repetitive sequence
12/13/2000CN1276380A Human reduced nicotinamide adenine nucleotie-cytochrome b5 reductase and its coding sequence
12/13/2000CN1059466C Method for identifying individuals suffering from cellular abnormality
12/13/2000CN1059465C Method for diagnosing disorder by determining expression of GAGE tumor rejection antigen precursors
12/12/2000US6160109 Preparation of phosphorothioate and boranophosphate oligomers
12/12/2000US6160107 Nucleic acids encoding antigens associated with polymyositis and dermatomositis
12/12/2000US6160106 Nucleotide sequences which code polypeptides which prevent gene expression; for use as diagnostic screening tools in the detection and treatment of cancer; anticarcinogenic agents
12/12/2000US6160105 Detecting toxic effect of compound; incubate sample with toxin, isolate nucleotide sequences, hybridize nucleotide sequences to complement, compare level of nucleotide expression with a control
12/12/2000US6160104 Markers for peroxisomal proliferators
12/12/2000US6160103 Conjugates of an oligonucleotide/electronic conductor polymer with a molecule of interest, and their uses
12/12/2000US6160088 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins
12/12/2000US6159951 2'-O-amino-containing nucleoside analogs and polynucleotides
12/12/2000US6159939 Method for inhibition of viral morphogenesis
12/12/2000US6159751 Development of DNA probes and immunological reagents of human tumor associated antigens
1 ... 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 ... 3003